These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

837 related items for PubMed ID: 15692792

  • 1. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T, Kimura T, Kurokawa F, Aoyama K, Ishikawa T, Tajima K, Yokoyama Y, Takami T, Omori K, Kawaguchi K, Tsuchiya M, Terai S, Sakaida I, Okita K.
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [Abstract] [Full Text] [Related]

  • 2. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.
    Ando E, Tanaka M, Yamashita F, Kuromatsu R, Yutani S, Fukumori K, Sumie S, Yano Y, Okuda K, Sata M.
    Cancer; 2002 Aug 01; 95(3):588-95. PubMed ID: 12209752
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A, Toyoda M, Hamada T, Hagiwara S, Yanagisawa M, Kosone T, Arai H, Abe T, Takagi H.
    Gan To Kagaku Ryoho; 2007 May 01; 34(5):729-34. PubMed ID: 17496446
    [Abstract] [Full Text] [Related]

  • 4. Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma.
    Ueshima K, Kudo M, Takita M, Nagai T, Tatsumi C, Ueda T, Kitai S, Ishikawa E, Yada N, Inoue T, Hagiwara S, Minami Y, Chung H.
    Oncology; 2010 Jul 01; 78 Suppl 1():148-53. PubMed ID: 20616598
    [Abstract] [Full Text] [Related]

  • 5. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY, Cheong JY, Cho SW, Sim SJ, Kim JS, Choi SJ, Choi JW, Kwon HC, Lee KM, Kim JK, Won JH, Yoo BM, Lee KJ, Hahm KB, Kim JH.
    Korean J Hepatol; 2006 Mar 01; 12(1):65-73. PubMed ID: 16565607
    [Abstract] [Full Text] [Related]

  • 6. [Long-term outcome of advanced hepatocellular carcinoma that received transarterial hepatic chemotherapy].
    Masutani S, Shimizu J, Tatsuta M, Masuda F, Imamura H, Ishida H, Furukawa H, Tomotsu K, Yura M, Obana T, Kitamura S, Saeki N, Inoue Y, Takamura M, Ohnishi H.
    Gan To Kagaku Ryoho; 2003 Oct 01; 30(11):1579-82. PubMed ID: 14619468
    [Abstract] [Full Text] [Related]

  • 7. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
    Hamada A, Yamakado K, Nakatsuka A, Takaki H, Akeboshi M, Takeda K.
    J Vasc Interv Radiol; 2004 Aug 01; 15(8):835-41. PubMed ID: 15297587
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapy using 5-fluorouracil, mitoxantrone, and cisplatin for patients with advanced hepatocellular carcinoma: an analysis of 63 cases.
    Yang TS, Chang HK, Chen JS, Lin YC, Liau CT, Chang WC.
    J Gastroenterol; 2004 Aug 01; 39(4):362-9. PubMed ID: 15168248
    [Abstract] [Full Text] [Related]

  • 9. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
    Kuroda M, Kobayashi Y, Urawa N, Yamamoto M, Mifuji R, Araki J, Tanaka H, Horiike S, Itani T, Furjita N, Konishi M, Iwasa M, Kaito M, Adachi Y.
    Hepatogastroenterology; 2007 Mar 01; 54(74):518-21. PubMed ID: 17523311
    [Abstract] [Full Text] [Related]

  • 10. [Hepatic arterial infusion chemotherapy (HAIC)--hepatocellular carcinoma].
    Osuga K, Murakami T, Nakata S, Tomoda K, Nagano H, Monden M, Nakamura H.
    Gan To Kagaku Ryoho; 2004 Dec 01; 31(13):2114-7. PubMed ID: 15628754
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy of repeated hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Sim MK, Kim DY, Park JY, Kim JK, Kim SA, Ahn SH, Chon CY, Moon YM, Won JY, Lee DY, Han KH.
    Korean J Hepatol; 2005 Sep 01; 11(3):268-74. PubMed ID: 16177553
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Successful treatment for advanced hepatocellular carcinoma by hepatic arterial infusion of CDDP powder as second-line chemotherapy].
    Gen Y, Kimura H, Akitake R, Sakai A, Fukui A, Takao T, Ikezawa S, Masuda A, Takashima H, Funatsu E, Nakamura H, Okuyama Y, Arai M, Yagi N, Kutsumi H, Fujimoto S, Takeuchi Y.
    Gan To Kagaku Ryoho; 2006 Apr 01; 33(4):505-8. PubMed ID: 16612162
    [Abstract] [Full Text] [Related]

  • 15. [Study of continuous arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil for patients with hepatocellular carcinoma].
    Takao T, Nisida M, Maeda Y, Mori N, Tamesa T, Tangoku A, Oka M.
    Gan To Kagaku Ryoho; 1999 Oct 01; 26(12):1836-40. PubMed ID: 10560407
    [Abstract] [Full Text] [Related]

  • 16. Hepatic arterial infusion chemotherapy in combination with pegylated interferon-α-2b for advanced hepatocellular carcinoma.
    Okita K, Yamasaki T, Hamabe S, Saeki I, Harima Y, Terai S, Sakaida I.
    Hepatogastroenterology; 2012 Oct 01; 59(114):533-7. PubMed ID: 22353519
    [Abstract] [Full Text] [Related]

  • 17. Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma.
    Kawaoka T, Aikata H, Takaki S, Katamura Y, Hiramatsu A, Waki K, Takahashi S, Hieda M, Toyota N, Ito K, Chayama K.
    Cardiovasc Intervent Radiol; 2009 Jul 01; 32(4):687-94. PubMed ID: 19444503
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW, Park YM, Bae SH, Choi JY, Yoon SK, Chang UI, Nam SW, Kim BS.
    Cancer Chemother Pharmacol; 2004 Nov 01; 54(5):415-20. PubMed ID: 15235823
    [Abstract] [Full Text] [Related]

  • 19. Randomized, phase II study comparing interferon combined with hepatic arterial infusion of fluorouracil plus cisplatin and fluorouracil alone in patients with advanced hepatocellular carcinoma.
    Yamashita T, Arai K, Sunagozaka H, Ueda T, Terashima T, Yamashita T, Mizukoshi E, Sakai A, Nakamoto Y, Honda M, Kaneko S.
    Oncology; 2011 Nov 01; 81(5-6):281-90. PubMed ID: 22133996
    [Abstract] [Full Text] [Related]

  • 20. [A case of hepatocellular carcinoma responding to hepatic arterial infusion chemotherapy with low-dose cisplatin and 5-fluorouracil].
    Takeda Y, Hasuike Y, Tsujinaka T.
    Gan To Kagaku Ryoho; 2001 Oct 01; 28(11):1712-7. PubMed ID: 11708016
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.